ArticleJournal of general internal medicine2026
Antibiotic Use in Patients with Acute Exacerbations of Chronic Obstructive Pulmonary Disease: A Multicenter Retrospective Cohort Study.
Article in Journal of general internal medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
Abstract
backgroundThe use of antibiotics in acute exacerbations of chronic obstructive pulmonary disease (AECOPD) with clear evidence of pneumonia is considered standard practice. However, without radiographic bacterial pneumonia, the net impact of antibiotics is equivocal.
objectiveTo study physician-level practice variation in antibiotic prescribing and associated outcomes for patients hospitalized with AECOPD without pneumonia.
designRetrospective cohort study.
participantsPatients admitted to general internal medicine wards across seven hospitals in Ontario, Canada, between April 2010 and December 2020 with AECOPD without pneumonia. Each hospitalization was attributed to the admitting physician. EXPOSURE: To avoid indication bias (sicker patients are more likely to receive antibiotics), the main exposure was the propensity of a patient's physician to prescribe antibiotics in AECOPD, measured by the proportion of their AECOPD patients treated with antibiotics. MAIN MEASURES: We studied four outcomes using multivariable regression to adjust for patient baseline characteristics: in-patient mortality, intensive care unit (ICU) transfer, 30-day hospital readmission, and hospital length of stay (LOS). KEY
resultsThe cohort included 2043 hospitalizations cared for by 106 physicians. Overall, 52.1% of patients were treated with antibiotics. Physician antibiotic prescribing ranged from 15.2 to 96.2% (median 69.2%, IQR 50.9 to 76.5). Physician propensity to prescribe antibiotics was not significantly associated with patient-level clinical outcomes, including in-patient mortality (adjusted odds ratio [aOR] 1.05, 95% confidence intervals [CI] = 1.00 to 1.10), ICU transfer (aOR 1.04, 95%CI = 1.00 to 1.09), 30-day readmission (aOR 1.01, 95%CI = 0.99 to 1.02), and hospital LOS (adjusted risk ratio 1.00, 95%CI = 0.99 to 1.00) (all not statistically significant).
conclusionsMore than half of patients hospitalized to a medical ward with AECOPD without pneumonia were treated with antibiotics. Antibiotic prescribing varied widely across physicians, and greater prescribing was not associated with better outcomes.
Identifiers
41615524What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.